Your browser doesn't support javascript.
Bacterial co-infections and antimicrobial resistance associated with the Coronavirus Disease 2019 infection.
Teklemariam, Addisu D; Hashem, Anwar M; Saber, Saber H; Almuhayawi, Mohammed S; Haque, Shafiul; Abujamel, Turki S; Harakeh, Steve.
  • Teklemariam AD; Department of Biology, Faculty of sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Hashem AM; Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Saber SH; Vaccines and immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Almuhayawi MS; Molecular Cell Biology Laboratory, Department of Zoology, Faculty of Science, Assiut University, Asyut, Egypt.
  • Haque S; Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Abujamel TS; Research and Scientific Studies Unit, College of Nursing and Allied Health Sciences, Jazan University, Jazan, Saudi Arabia.
  • Harakeh S; Vaccines and immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Biotechnol Genet Eng Rev ; : 1-22, 2022 Sep 19.
Article in English | MEDLINE | ID: covidwho-2037132
ABSTRACT
Bacterial co-infections are typically associated with viral respiratory tract infections and pose a significant public health problem around the world. COVID-19 infection damages tissues lining the respiratory track and regulates immune cells/cytokines leading to microbiome dysbiosis and facilitating the area to be colonized by pathogenic bacterial agents. There have been reports of different types of bacterial co-infection in COVID-19 patients. Some of these reports showed despite geographical differences and differences in hospital settings, bacterial co-infections are a major cause of morbidity and mortality in COVID-19 patients. The inappropriate use of antibiotics for bacterial infections, particularly broad-spectrum antibiotics, can also further complicate the infection process, often leading to multi drug resistance, clinical deterioration, poor prognosis, and eventually death. To this end, researchers must establish a new therapeutic approach to control SARS-CoV-2 and the associated microbial coinfections. Hence, the aim of this review is to highlight the bacterial co-infection that has been recorded in COVID-19 patients and the status of antimicrobial resistance associated with the dual infections.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Biotechnol Genet Eng Rev Year: 2022 Document Type: Article Affiliation country: 02648725.2022.2122297

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Biotechnol Genet Eng Rev Year: 2022 Document Type: Article Affiliation country: 02648725.2022.2122297